Roy S. Herbst, MD, PhD
Yale Cancer Center and Smilow Cancer Hospital
Summanta (Monty) Pal, MD
City of Hope
Karim Chamie, MDUCLA Health
Overall survival from a randomized study for advanced NSCLC previously treated with immunotherapy
Cabozantinib (C) in combination with atezolizumab (A) in urothelial carcinoma (UC)
Final clinical results of pivotal trial of IL-15RαFc superagonist N-803 with BCG in BCG-unresponsive CIS and papillary NMIBC
Interested In Advertising With Us?Click Here To Schedule A MeetingPhone: 949-394-4735Email: advertise@oncologytube.com
Medicus Networks Inc., 45121 Morgan Heights Rd., Temecula, California 92592, United States, (951) 944-2173
Unsubscribe Manage preferences